Patents by Inventor Andreas Luxenburger

Andreas Luxenburger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8987504
    Abstract: The invention relates to a process for the aminohydroxylation of alkenes using N-oxycarbamate reagents, e.g. N-acyloxycarbamate, N-alkyloxycarbonyloxycarbamate and N-aralkoxycarbonyloxycarbamate reagents. The invention particularly relates to an intermolecular aminohydroxylation reaction that can be carried out in the absence of added base. The invention also relates to novel N-oxycarbamate reagents that are stable crystalline materials. The process of the invention is useful in the synthesis of compounds having a vicinal amino alcohol moiety, such as biologically active compounds.
    Type: Grant
    Filed: June 20, 2011
    Date of Patent: March 24, 2015
    Assignee: Victoria Link Limited
    Inventors: Simon Peter Harold Mee, Andreas Luxenburger, Lawrence Daniel Harris
  • Publication number: 20130274479
    Abstract: The invention relates to a process for the aminohydroxylation of alkenes using N-oxycarbamate reagents, e.g. N-acyloxycarbamate, N-alkyloxycarbonyloxycarbamate and N-aralkoxycarbonyloxycarbamate reagents. The invention particularly relates to an intermolecular aminohydroxylation reaction that can be carried out in the absence of added base. The invention also relates to novel N-oxycarbamate reagents that are stable crystalline materials. The process of the invention is useful in the synthesis of compounds having a vicinal amino alcohol moiety, such as biologically active compounds.
    Type: Application
    Filed: June 20, 2011
    Publication date: October 17, 2013
    Applicant: INDUSTRIAL RESEARCH LIMITED
    Inventors: Simon Peter Harold Mee, Andreas Luxenburger, Lawrence Daniel Harris
  • Patent number: 7485742
    Abstract: A new class of non-glycosidic and non-peptidic inhibitors of selectins with low molecular weight according to the general formula 1 is described, as well as methods for their production. These compounds represent a new class of non-toxic, in vivo anti-inflammatory effective inhibitors of selectins, and do not exhibit the disadvantages of the glycosidic inhibitor complexes, and are furthermore more potent in vitro, compared to the known drug bimosiamose. Furthermore, medicaments containing the compounds and their uses in the treatment of diseases are described.
    Type: Grant
    Filed: July 26, 2005
    Date of Patent: February 3, 2009
    Assignee: Johannes Gutenberg-Universität Mainz
    Inventors: Gerd Dannhardt, Holger Ulbrich, Philip Prech, Andreas Luxenburger
  • Publication number: 20070276036
    Abstract: A new class of non-glycosidic and non-peptidic inhibitors of selectins with low molecular weight according to the general formula 1 is described, as well as methods for their production. These compounds represent a new class of non-toxic, in vivo anti-inflammatory effective inhibitors of selectins, and do not exhibit the disadvantages of the glycosidic inhibitor complexes, and are furthermore more potent in vitro, compared to the known drug bimosiamose. Furthermore, medicaments containing the compounds and their uses in the treatment of diseases are described.
    Type: Application
    Filed: July 26, 2005
    Publication date: November 29, 2007
    Inventors: Gerd Dannhardt, Holger Ulbrich, Philip Prech, Andreas Luxenburger